Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
about
Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signaturesQuantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoringFifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data.Oncoplastic technique in breast conservative surgery for locally advanced breast cancerTumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.Young women with locally advanced breast cancer who achieve breast conservation after neoadjuvant chemotherapy have a low local recurrence rate.Expression of multidrug resistance proteins in invasive ductal carcinoma of the breastOutcome of neoadjuvant chemotherapy in locally advanced breast cancer: A tertiary care centre experience.Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)Staging of breast cancer in the neoadjuvant setting.Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancerManagement of local recurrence of breast cancer.Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.Breast conservation in locally advanced breast cancer.Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice.The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancerPreoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival.Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel.The role of oncoplastic breast conserving treatment for locally advanced breast tumors. A matching case-control studyState of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments.High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer.DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer.Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up.Osteonecrosis of the jaw associated with everolimus: A case report.Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.Local Recurrence after Breast-Conserving Surgery and Mastectomy Following Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer - a Meta-AnalysisImpact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.The integrated evaluation of the results of oncoplastic surgery for locally advanced breast cancer.Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.Pre-operative Endocrine Therapy.Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and meta-analysis.Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.Evaluation of Surgical Outcomes of Oncoplasty Breast Surgery in Locally Advanced Breast Cancer and Comparison with Conventional Breast Conservation Surgery.Noninflammatory breast carcinoma with skin involvement.Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
P2860
Q24812541-CDCFA21C-65E1-4DD5-81A2-42048F345708Q25257743-3E1A5B37-A825-42A3-BCDE-A261CA4D7656Q28270514-EDB7A1A2-7A12-420E-8B52-B852BDCCB17FQ30981785-6D944CB3-1564-4164-97A5-AFE72D419852Q33973166-E8EFC753-38C0-458E-8499-18AADC0CE7BCQ34158197-7569066F-46F0-41FC-AAA8-15BB56CFD2B4Q34206297-DC6512BA-01C4-48F9-95EF-785C9C4191F4Q34293229-16D9A6D0-9414-4E0C-B5D0-69FB93C21F95Q34368298-41B97DA0-8622-485C-A7D3-432A2D7522F8Q35000874-27406A6E-EEAD-466B-BA53-6440EEC0BB7AQ35638695-CA4E8922-4FFC-4B5E-BE79-9D3103FFB426Q35657487-EFEF9F3B-5D9D-400A-ADC1-266FCA9A66DDQ35728692-B8B7EE14-2D02-43E1-B43B-7B680A7344E0Q35985784-C422FAE2-B7A4-4B20-B8D4-5411DC5A1882Q36169992-234DCDC2-AD43-4F1A-9F51-CE02ED975713Q36546612-77C0C14C-9AE2-4B13-8F88-24A20A58D820Q36816914-AF4D0D64-3334-4F51-B2FC-9B54299A4039Q36848102-8BADDB55-9F88-41DE-A9F6-AE2E2FB2DA29Q36917231-8AF0E14D-6318-4E8E-B1C4-6887D3DF8F85Q37055326-EF552DAF-F63C-46A4-B9F4-5065AC74A1A2Q37171652-2B545668-4EB3-4310-87C7-8243E4A212E6Q37244111-EF782B57-3A67-46CD-B700-3EA484A6D2C9Q37288041-A3312D54-1B71-44B5-98BE-1FF8E990EEE5Q37301839-033879FE-98A7-45F6-85B2-2BBB747D14D5Q37697506-C4005E9A-5696-4733-AF4F-2E0AC2F83FD6Q37701817-16D16B70-99A0-46F6-8D81-2A607DBF7771Q37701896-4E065BF7-C8BA-4AD3-86C3-4E967EED6A37Q38253593-A13E2259-A040-4D12-9A30-9FDA865BBE68Q38452286-4A4B6049-98AA-43DB-8762-8C92E09523D2Q38832422-E8BE93B5-8A5C-4DAA-8D49-C4AE9206A55CQ39030146-6E98E6E4-756B-476A-8874-BE5B6D0989F8Q42485941-C69A69D0-CA94-459D-A8D1-2AB8BDB61B42Q43457976-BFDFFEEB-EAD2-4629-AB64-162CBDE952BCQ44354897-59A83F32-2DB1-400F-856E-853121737484Q46143861-C99116BF-C968-4914-8C15-DC7BB6F7FF40Q46429749-3D6E5577-BE6E-4C5B-937B-8108E6A4A700Q47101783-FC4ABBC1-7160-4F6F-8DB1-76A15B7C9BF9Q47103183-ABDCF5B5-A12C-4D7E-8647-E112AAF170F8Q47239440-DC42F0EA-615C-4B60-93DB-B3158558D138Q51017227-752555DD-FB89-4832-9AEC-9B437C253A6E
P2860
Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Long-term outcome of neoadjuva ...... ng local control and survival.
@ast
Long-term outcome of neoadjuva ...... ng local control and survival.
@en
Long-term outcome of neoadjuva ...... ng local control and survival.
@nl
type
label
Long-term outcome of neoadjuva ...... ng local control and survival.
@ast
Long-term outcome of neoadjuva ...... ng local control and survival.
@en
Long-term outcome of neoadjuva ...... ng local control and survival.
@nl
prefLabel
Long-term outcome of neoadjuva ...... ng local control and survival.
@ast
Long-term outcome of neoadjuva ...... ng local control and survival.
@en
Long-term outcome of neoadjuva ...... ng local control and survival.
@nl
P2093
P2860
P1433
P1476
Long-term outcome of neoadjuva ...... ng local control and survival.
@en
P2093
Benjamin F Calvo
Carolyn Sartor
David W Ollila
Dominic T Moore
Julian Rosenman
Lisa A Carey
Lynda Sawyer
Mark Graham
William G Cance
P2860
P304
295-302; discussion 302-3
P356
10.1097/00000658-200209000-00006
P407
P577
2002-09-01T00:00:00Z